Spots Global Cancer Trial Database for Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Official Title: Correlation Between Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Study ID: NCT02879968

Conditions

Head and Neck Cancer

Interventions

Non-interventional study

Study Description

Brief Summary: Correlation between serum squamous cell carcinoma antigen level and tumor volume in Head and Neck Cancer is to determine a correlation between level of serum squamous cell carcinoma antigen and tumor volume in Head and Neck Caner measured by cross-sectional imaging.

Detailed Description: The study is a cross-sectional study. A single measurement of serum squamous cell carcinoma antigen level is performed in the eligible Head and Neck squamous cell carcinoma patients. The study tool measuring serum squamous cell carcinoma antigen level is ARCHITECT SCC (Abbott). The gross tumor volume in the cross sectional imaging obtained within 2 weeks of each patient is calculated with the typical ellipsoid formula. Correlation between both parameters will be determined.